CLVS
LPL Financial’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-14,133
| Closed | -$17K | – | 4584 |
|
|
2022
Q3 | $17K | Sell |
14,133
-21,050
| -60% | -$25.3K | ﹤0.01% | 4312 |
|
|
2022
Q2 | $63K | Buy |
35,183
+1,870
| +6% | +$3.35K | ﹤0.01% | 4173 |
|
|
2022
Q1 | $67K | Sell |
33,313
-500
| -1% | -$1.01K | ﹤0.01% | 4011 |
|
|
2021
Q4 | $92K | Sell |
33,813
-2,690
| -7% | -$7.32K | ﹤0.01% | 4140 |
|
|
2021
Q3 | $163K | Sell |
36,503
-22,182
| -38% | -$99.1K | ﹤0.01% | 4014 |
|
|
2021
Q2 | $340K | Sell |
58,685
-31,720
| -35% | -$184K | ﹤0.01% | 3481 |
|
|
2021
Q1 | $635K | Buy |
90,405
+33,825
| +60% | +$238K | ﹤0.01% | 2812 |
|
|
2020
Q4 | $272K | Buy |
56,580
+24,327
| +75% | +$117K | ﹤0.01% | 3276 |
|
|
2020
Q3 | $188K | Buy |
32,253
+10,325
| +47% | +$60.2K | ﹤0.01% | 3207 |
|
|
2020
Q2 | $148K | Buy |
+21,928
| New | +$148K | ﹤0.01% | 3177 |
|
|
2018
Q3 | – | Sell |
-5,123
| Closed | -$233K | – | 3310 |
|
|
2018
Q2 | $233K | Sell |
5,123
-338
| -6% | -$15.4K | ﹤0.01% | 2852 |
|
|
2018
Q1 | $288K | Buy |
5,461
+2,184
| +67% | +$115K | ﹤0.01% | 2633 |
|
|
2017
Q4 | $223K | Buy |
3,277
+710
| +28% | +$48.3K | ﹤0.01% | 2719 |
|
|
2017
Q3 | $212K | Buy |
2,567
+224
| +10% | +$18.5K | ﹤0.01% | 2620 |
|
|
2017
Q2 | $219K | Buy |
+2,343
| New | +$219K | ﹤0.01% | 2512 |
|